Benjamin Haibe-Kains

Cited by

	All	Since 2018
Citations	31531	19144
h-index	83	65
i10-index	185	169

4500

2250

1125

3375

20072008200920102011201220132014201520162017201820192020202120222023160 300 551 827 992 1123 1189 1340 1545 1852 2245 2379 2901 3392 4186 4481 1789

Public access

View all

163 articles

7 articles

available

not available

Based on funding mandates

Co-authors

Christos SotiriouUniversité Libre de BruxellesVerified email at bordet.be
Christine DesmedtKU LeuvenVerified email at kuleuven.be
John QuackenbushHarvard T.H. Chan School of Public Health, Channing Division of Network Medicine, and Dana-FarberVerified email at hsph.harvard.edu
Gianluca BontempiUniversité Libre de BruxellesVerified email at ulb.ac.be
Hugo AertsDirector AI in Medicine (AIM) @ Harvard-MGB | Professor @ MaastrichtUVerified email at dfci.harvard.edu
Petr SmirnovPostdoctoral Fellow, EMBLVerified email at embl.de
Mauro DelorenziSIB Swiss Institute of BioinformaticsVerified email at unil.ch
Anna GoldenbergScientist, SickKids Research Institute; Assistant Professor Department of Computer Science, University of TorontoVerified email at utoronto.ca
Marc BuyseChief Scientific Officer, IDDIVerified email at iddi.com
Zhaleh SafikhaniPost doctoral fellowVerified email at utoronto.ca
Michail IgnatiadisMedical Oncology Department, Institut Jules Bordet, Université Libre de BruxellesVerified email at bordet.be
Patrick GrossmannPh.D. Candidate conducting research at Harvard Medical School, Dana-Farber Cancer Institute, BWHVerified email at jimmy.harvard.edu
Fatima CardosoBreast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, PortugalVerified email at fundacaochampalimaud.pt
Philippe LambinProfessor of Precision Medicine, Maastricht UniversityVerified email at maastrichtuniversity.nl
Emmanuel Rios VelazquezBusiness Development Manager - Precision Health & Nutrition @imec - OnePlanet Research CenterVerified email at imec.nl
Adrian L HarrisProfessor of Medical Oncology, Oxford UniversityVerified email at oncology.ox.ac.uk
Chintan ParmarPathAI (Current) | [Novartis, Harvard-DFCI-BWH, ISI-Kolkata] (Previous)Verified email at dfci.harvard.edu
Sandeep K. SinghalAssistant Professor and ScientistVerified email at und.edu
Stefan MichielsHead Office Biostatistics & Epidemiology, Gustave Roussy; Head Oncostat, Inserm Univ. Paris SaclayVerified email at gustaveroussy.fr
Andre DekkerProfessor of Clinical Data Science, MAASTRO Clinic, Maastricht University, GROW, Maastricht UMC+Verified email at maastro.nl

Benjamin Haibe-Kains

Scientist (Principal Investigator), Princess Margaret Cancer Centre, University Health Network

Verified email at uhnresearch.ca - Homepage

Bioinformatics Machine Learning Genomics Computational Biology Biomedicine


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach HJWL Aerts, ER Velazquez, RTH Leijenaar, C Parmar, P Grossmann, ... Nature communications 5 (1), 4006, 2014	4157	2014
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ... Journal of the National Cancer Institute 98 (4), 262-272, 2006	2225	2006
Similarity network fusion for aggregating data types on a genomic scale B Wang, AM Mezlini, F Demir, M Fiume, Z Tu, M Brudno, B Haibe-Kains, ... Nature methods 11 (3), 333-337, 2014	1459	2014
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ... Clinical cancer research 13 (11), 3207-3214, 2007	1066	2007
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ... Breast Cancer Research 10 (4), 1-11, 2008	1007	2008
Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade S Loi, B Haibe-Kains, C Desmedt, F Lallemand, AM Tutt, C Gillet, P Ellis, ... Journal of clinical oncology 25 (10), 1239, 2007	916	2007
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes C Desmedt, B Haibe-Kains, P Wirapati, M Buyse, D Larsimont, ... Clinical cancer research 14 (16), 5158-5165, 2008	912	2008
CD4⁺ follicular helper T cell infiltration predicts breast cancer survival C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ... The Journal of clinical investigation 123 (7), 2873-2892, 2013	896	2013
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma TP Coroller, P Grossmann, Y Hou, ER Velazquez, RTH Leijenaar, ... Radiotherapy and Oncology 114 (3), 345-350, 2015	690	2015
Robust radiomics feature quantification using semiautomatic volumetric segmentation C Parmar, E Rios Velazquez, R Leijenaar, M Jermoumi, S Carvalho, ... PloS one 9 (7), e102107, 2014	563	2014
Inconsistency in large pharmacogenomic studies B Haibe-Kains, N El-Hachem, NJ Birkbak, AC Jin, AH Beck, HJWL Aerts, ... Nature 504 (7480), 389-393, 2013	512	2013
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer S Loi, S Pommey, B Haibe-Kains, PA Beavis, PK Darcy, MJ Smyth, ... Proceedings of the National Academy of Sciences 110 (27), 11091-11096, 2013	473	2013
Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer C Parmar, RTH Leijenaar, P Grossmann, E Rios Velazquez, J Bussink, ... Scientific reports 5 (1), 1-10, 2015	455	2015
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen S Loi, B Haibe-Kains, C Desmedt, P Wirapati, F Lallemand, AM Tutt, ... BMC genomics 9 (1), 1-12, 2008	414	2008
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor–positive breast cancer S Loi, B Haibe-Kains, S Majjaj, F Lallemand, V Durbecq, D Larsimont, ... Proceedings of the National Academy of Sciences 107 (22), 10208-10213, 2010	396	2010
survcomp: an R/Bioconductor package for performance assessment and comparison of survival models MS Schröder, AC Culhane, J Quackenbush, B Haibe-Kains Bioinformatics 27 (22), 3206-3208, 2011	382	2011
Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling HA Azim Jr, S Michiels, PL Bedard, SK Singhal, C Criscitiello, M Ignatiadis, ... Clinical cancer research 18 (5), 1341-1351, 2012	381	2012
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer Y Li, L Zou, Q Li, B Haibe-Kains, R Tian, Y Li, C Desmedt, C Sotiriou, ... Nature medicine 16 (2), 214-218, 2010	376	2010
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification B Stamatopoulos, N Meuleman, B Haibe-Kains, P Saussoy, ... Blood, The Journal of the American Society of Hematology 113 (21), 5237-5245, 2009	375	2009
A three-gene model to robustly identify breast cancer molecular subtypes B Haibe-Kains, C Desmedt, S Loi, AC Culhane, G Bontempi, ... Journal of the National Cancer Institute 104 (4), 311-325, 2012	347	2012

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors